Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

1.19
Delayed Data
As of 1:25pm ET
 -0.02 / -1.65%
Today’s Change
0.81
Today|||52-Week Range
3.48
-9.85%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.21
Today’s open1.26
Day’s range1.19 - 1.27
Volume66,033
Average volume (3 months)141,971
Market cap$30.8M
Dividend yield--
Data as of 1:25pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+40.42%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
FCSCFibrocell Science In...-0.03-1.42%
XBIOXenetic Biosciences ...+0.08+2.17%
OHRPOHR Pharmaceutical I...+0.02+2.38%
ADHDAlcobra Ltd+0.01+0.88%
Data as of 1:44pm ET, 03/29/2017

Financials

Last reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Larry M. Dillaha
CFO, Secretary &
Chief Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts


Search for Jobs